Armstrong, April W, Kim A Papp, Joe Zhuo, Brandon Becker, Yichen Zhong, Jennifer L Beaumont, Michael DeRosa, Renata M Kisa, Subhashis Banerjee, and Bruce Strober. “Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Moderate to Severe Plaque Psoriasis: Correlations Between Patient-Reported Outcomes and Clinical Responses in the Phase 3 Clinical Trials POETYK PSO-1 and POETYK PSO-2”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s63. Accessed September 20, 2024. https://dermsquared.com/skin/article/view/1818.